Related Experiment Video
Updated: Aug 6, 2026

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion
Published on: July 3, 2026
Yersiniabactin-producing adherent-invasive Escherichia coli exploit host glycolysis to drive macrophage HIF-1α
Marlus S Pedrosa1, Ju-Hyun Ahn1, John D Sears1
1Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Abstract:
The siderophore yersiniabactin (Ybt) produced by a subset of intestinal adherent-invasive Escherichia coli (AIEC) drive intestinal fibrosis in murine model of Crohn's disease (CD). This is linked to the Ybt-induced disruption of host metal homeostasis and activation of the hypoxia-inducible factor 1-alpha (HIF-1α) in macrophages. Elevated glycolytic activity has been documented in both intestinal tissues and macrophages from patients with CD, indicating that metabolic reprogramming is a characteristic feature of the disease. Here, we show that HIF-1α stabilization by Ybt+ AIEC requires active host glycolysis. This effect is independent of Hif1a transcription and lipopolysaccharide stimulation and is not solely explained by intracellular bacterial load but instead relies on host metabolic activity. Mechanistically, Ybt+ AIEC activated the Akt-mTOR pathway to support HIF-1α translation. Inhibition of glycolysis suppressed this signaling axis, reducing HIF-1α translation and nuclear localization. Given the association between Ybt+ AIEC and fibrosis in CD, these findings suggest that targeting host glycolysis may limit AIEC-driven macrophage HIF-1α activation and fibrotic progression in CD patients.
Insights
Yersiniabactin-producing E. coli drives Crohn's disease fibrosis by activating hypoxia-inducible factor 1-alpha (HIF-1α) in macrophages. Targeting host glycolysis may limit this activation and disease progression.
Area of Science:
- Microbiology
- Immunology
- Gastroenterology
Background:
- Adherent-invasive Escherichia coli (AIEC) producing yersiniabactin (Ybt) are linked to intestinal fibrosis in Crohn's disease (CD).
- Ybt disrupts host metal homeostasis and activates hypoxia-inducible factor 1-alpha (HIF-1α) in macrophages.
- Metabolic reprogramming, including elevated glycolysis, is characteristic of CD.
Purpose of the Study:
- To investigate the role of host glycolysis in Ybt-mediated HIF-1α activation by AIEC.
- To elucidate the molecular mechanisms linking Ybt, glycolysis, and HIF-1α stabilization.
Main Methods:
- Utilized a murine model of CD and AIEC infection.
- Investigated the impact of glycolysis inhibition on HIF-1α activation and signaling pathways.
- Analyzed Akt-mTOR pathway activation and HIF-1α translation and nuclear localization.
Main Results:
- HIF-1α stabilization by Ybt+ AIEC requires active host glycolysis, independent of Hif1a transcription or LPS.
- Host metabolic activity, not solely bacterial load, drives HIF-1α activation.
- Ybt+ AIEC activates the Akt-mTOR pathway, promoting HIF-1α translation; glycolysis inhibition disrupts this.
Conclusions:
- Host glycolysis is essential for Ybt-mediated HIF-1α activation in macrophages by AIEC.
- Targeting host glycolysis presents a potential therapeutic strategy to limit AIEC-driven fibrosis in CD.
More Related Videos
08:38Using a Bacterial Pathogen to Probe for Cellular and Organismic-level Host Responses
Published on: February 22, 2019
09:49Investigation of Microbial Cooperation via Imaging Mass Spectrometry Analysis of Bacterial Colonies Grown on Agar and in Tissue During Infection
Published on: November 18, 2022
Related Concept Videos
Stringent Response in E. coli
Amebiasis
Determinants of Bacterial Pathogenicity and Virulence